Author

K. Miyaji

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#protein folding Open access Nov 2026

Phase II randomized non-inferiority trial comparing the humoral immunogenicity of NDV-HXP-S and BNT162b2 vaccines in Brazil

This was a multicenter, randomized, double-blind, active-controlled and non-inferiority Phase II clinical trial, to evaluate the immunogenicity and safety of a fifth-dose booster of NDV-HXP-S, an egg-derived, inactivated COVID-19 vectored-vaccine virus using the Newcastle disease virus.

É. J. F. Peixoto de Miranda, José Alfredo de Sousa Moreira, Ricardo Sobhie Diaz et al. · Scientific Reports · 0 citations

Open access Nov 2026

An open label, uncontrolled clinical trial of immunogenicity and safety of yellow fever vaccine in adults with chronic kidney disease as compared to immunocompetent.

INTRODUCTION During a yellow fever (YF) epidemic in Brazil, vaccination campaigns targeting the entire population in the affected areas were conducted, bringing up an opportunity to prospectively evaluate YF vaccine's immunogenicity and safety in adults with chronic kidney disease (CKD). METHODS Open-label, uncontrol...

Amanda Caroline Ribeiro Sales, Camila de Melo Picone, Adriana de Souza Azevedo Soares et al. · Vaccine · 0 citations